227 related articles for article (PubMed ID: 9722815)
1. Drug abuse treatment as AIDS prevention.
Metzger DS; Navaline H; Woody GE
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):97-106. PubMed ID: 9722815
[TBL] [Abstract][Full Text] [Related]
2. Outreach-based HIV prevention for injecting drug users: a review of published outcome data.
Coyle SL; Needle RH; Normand J
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):19-30. PubMed ID: 9722807
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus prevention and the potential of drug abuse treatment.
Metzger DS; Navaline H
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S451-6. PubMed ID: 14648463
[TBL] [Abstract][Full Text] [Related]
4. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
Hartel DM; Schoenbaum EE
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
[TBL] [Abstract][Full Text] [Related]
5. HIV risk reduction in outpatient drug abuse treatment: individual and geographic differences.
Broome KM; Joe GW; Simpson DD
AIDS Educ Prev; 1999 Aug; 11(4):293-306. PubMed ID: 10494354
[TBL] [Abstract][Full Text] [Related]
6. HIV diagnoses among injection-drug users in states with HIV surveillance--25 states, 1994-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Jul; 52(27):634-6. PubMed ID: 12855944
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(13):329-32. PubMed ID: 19357632
[TBL] [Abstract][Full Text] [Related]
8. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
9. Community-based outreach HIV intervention for street-recruited drug users in Madras, India.
Kumar MS; Mudaliar S; Daniels D
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):58-66. PubMed ID: 9722810
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of risk behaviors for HIV infection among adults--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Apr; 50(14):262-5. PubMed ID: 11411830
[TBL] [Abstract][Full Text] [Related]
11. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
12. Health services research: drug use and human immunodeficiency virus in the United States.
Flanzer J
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S439-44. PubMed ID: 14648461
[TBL] [Abstract][Full Text] [Related]
13. HIV-associated risk behaviour among drug users at drug rehabilitation centres.
Fauziah MN; Anita S; Sha'ari BN; Rosli BI
Med J Malaysia; 2003 Jun; 58(2):268-72. PubMed ID: 14569748
[TBL] [Abstract][Full Text] [Related]
14. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric symptoms, risky behavior, and HIV infection.
Woody GE; Metzger D; Navaline H; McLellan T; O'Brien CP
NIDA Res Monogr; 1997; 172():156-70. PubMed ID: 9154270
[TBL] [Abstract][Full Text] [Related]
16. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
Islam MM; Conigrave KM
Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
[TBL] [Abstract][Full Text] [Related]
18. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
19. Trends in human immunodeficiency virus infection among drug users in a detoxification unit.
Muga R; Sanvisens A; Egea JM; Tor J; Rey-Joly C
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S404-9. PubMed ID: 14648455
[TBL] [Abstract][Full Text] [Related]
20. HIV infection among substance abusers in Thanyarak Institute On Drug Abuse, Thailand, 1987-2002.
Verachai V; Phutiprawan T; Sawanpanyalert P
J Med Assoc Thai; 2005 Jan; 88(1):76-9. PubMed ID: 15960222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
